Compare SBI Healthcare Opportunities Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
1.99
1.99
NAV
₹431.78
₹39.27
Fund Started
04 Jun 1999
25 Jun 2018
Fund Size
₹4063.64 Cr
₹6293.14 Cr
Exit Load
Exit load of 0.50% if redeemed within 15 days
Exit load of 1% if redeemed within 15 days.
1 Year
3.10%
4.52%
3 Year
24.26%
26.50%
5 Year
15.39%
16.00%
Equity
98.16%
97.62%
Cash
1.77%
2.35%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.11% |
Divi's Laboratories Ltd. | 6.59% |
Acutaas Chemicals Ltd. | 5.67% |
Apollo Hospitals Enterprise Ltd. | 5.48% |
Max Healthcare Institute Ltd. | 4.97% |
Lupin Ltd. | 4.10% |
Aster DM Healthcare Ltd. | 3.96% |
Torrent Pharmaceuticals Ltd. | 3.74% |
Aether Industries Ltd. | 3.56% |
Biocon Ltd. | 3.33% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Cipla Ltd. | 9.23% |
Mankind Pharma Ltd. | 7.01% |
Biocon Ltd. | 6.08% |
Dr. Reddy's Laboratories Ltd. | 5.97% |
Divi's Laboratories Ltd. | 5.91% |
Lupin Ltd. | 4.09% |
Alkem Laboratories Ltd. | 3.52% |
Syngene International Ltd. | 3.52% |
Aurobindo Pharma Ltd. | 3.30% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Jun 1999
25 Jun 2018
